
|Articles|December 18, 2015
Isis Pharmaceuticals Changes Company Name
December 18, 2015.
Advertisement
Isis Pharmaceuticals (Arlsbad, CA) today announced that the company has changed its name to Ionis Pharmaceuticals (pronounced "eye-OH-nis") for obvious reasons.
Lynne Parshall, chief operating officer at Ionis, said: "We decided to change our company name because, when people see or hear our name, we want them to think about the life-saving medicines we are developing."
In conjunction with the corporate name change, the company will trade on the NASDAQ Global Select Market under the new ticker symbol "IONS". In addition, it has a new website address:
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Biotech Industry’s Relationship with Real-Time Data: Q&A with Dr. Richard Graham
2
Does FDA's Shift From Two Pivotal Trials to One Represent a Genuine Evolution?
3
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
4
Pharmaceutical Executive Daily: FDA Approves Datroway
5




